Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP531627.RAEJakfEmWQRJW8e9Eds8P5tFMZISypNEZ9W6frVcLH-I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP531627.RAEJakfEmWQRJW8e9Eds8P5tFMZISypNEZ9W6frVcLH-I130_assertion type Assertion NP531627.RAEJakfEmWQRJW8e9Eds8P5tFMZISypNEZ9W6frVcLH-I130_head.
- NP531627.RAEJakfEmWQRJW8e9Eds8P5tFMZISypNEZ9W6frVcLH-I130_assertion description "[Our in vitro data suggest that reagents directed against LRP/LR or LRP mRNA such as antibodies, polysulfated glycans, or small interfering RNAs, previously shown to encompass an anti-prion activity by blocking or downregulating the prion receptor LRP/LR, might also be potential cancer therapeutics blocking metastasis by interfering with the LRP/LR-laminin interaction in neoplastic tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP531627.RAEJakfEmWQRJW8e9Eds8P5tFMZISypNEZ9W6frVcLH-I130_provenance.
- NP531627.RAEJakfEmWQRJW8e9Eds8P5tFMZISypNEZ9W6frVcLH-I130_assertion evidence source_evidence_literature NP531627.RAEJakfEmWQRJW8e9Eds8P5tFMZISypNEZ9W6frVcLH-I130_provenance.
- NP531627.RAEJakfEmWQRJW8e9Eds8P5tFMZISypNEZ9W6frVcLH-I130_assertion SIO_000772 18387633 NP531627.RAEJakfEmWQRJW8e9Eds8P5tFMZISypNEZ9W6frVcLH-I130_provenance.
- NP531627.RAEJakfEmWQRJW8e9Eds8P5tFMZISypNEZ9W6frVcLH-I130_assertion wasDerivedFrom befree-20150227 NP531627.RAEJakfEmWQRJW8e9Eds8P5tFMZISypNEZ9W6frVcLH-I130_provenance.
- NP531627.RAEJakfEmWQRJW8e9Eds8P5tFMZISypNEZ9W6frVcLH-I130_assertion wasGeneratedBy ECO_0000203 NP531627.RAEJakfEmWQRJW8e9Eds8P5tFMZISypNEZ9W6frVcLH-I130_provenance.